Brief: Aptose Biosciences Submits IND Application For CG-806
25/02/2019 12:18
Feb 25 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE BIOSCIENCES SUBMITS IND APPLICATION FOR CG-806
* APTOSE BIOSCIENCES INC - APTOSE WOULD SEEK ALLOWANCE FROM
FDA TO
MOVE INTO AML/MDS PATIENT POPULATION IN A SEPARATE PHASE1 TRIAL
Source text for Eikon: ID:nGNX6TWjWQ
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting